www.citaneuro.com

Cita is a neuropharmaceutical company focused on the development and commercialization of small molecule drug candidates for neurological diseases and disorders. Our strategy is to leverage our clinical expertise, business acumen and strategic partnerships to identify, acquire, develop and market novel drugs.

PRESS RELEASES

   Cita NeuroPharmaceuticals Inc. accepts offer by UK-based Vernalis plc